For investors, it is critical to know the details of how a cannabis company in this hypergrowth industry plans to bridge the gap between its current money-losing reality and the vision of a profitable future.
Kevin Huhn
Kevin Huhn's Latest Posts
Cannabis comp tables as of Aug. 26, 2019
This comp table provides a benchmark for private investors to evaluate existing and future investments and a menu for public investors to peruse.
Cannabis retailers should embrace out-of-state consumers – after they’ve taken appropriate steps
Medical and recreational cannabis retail stores near state borders have tremendous business opportunities.
Cannabis retailer Green Growth inks first equity raise
Ohio-based Green Growth Brands, which last month agreed to buy a multistate operator that sells both medical and recreational marijuana, completed an initial equity raise for 50.2 million Canadian dollars ($37.8 million). Green Growth said in...
How much is your slice of the marijuana pie worth?
Warrants can align stakeholder incentives with shareholder interests, but they complicate the share count at different valuations and can cloud what you really own.
Investor Intelligence to host exclusive webinar on Q2 cannabis investing trends
In a special webinar from MJBizDaily's Investor Intelligence, Viridian Capital Advisors executives Scott Greiper and Harrison Phillips will review Q2 investing trends and the outlook for the marijuana industry for the next 12-18 months. This special live webinar on...
MJBizDaily’s Investor Intelligence launches cannabis comp tables
This comp table provides a benchmark for private investors to evaluate existing and future investments as well as a menu for public investors to peruse.
Cannabis comp tables as of Aug. 19, 2019
This comp table provides a benchmark for private investors to evaluate existing and future investments and a menu for public investors to peruse.
As cannabis industry grows, opportunities in testing rise
Given the skyrocketing demand for cannabis and its newly found legitimacy, we anticipate increased government scrutiny and a need for more testing.
Lab sector could be cannabis’ next frontier
Given the skyrocketing demand for cannabis and its newly found legitimacy, we anticipate increased government scrutiny and a need for more testing – creating a new investment opportunity.
What cannabis sales growth rates may be hiding
Sales growth rates play a huge role in determining the value of a cannabis investment. However, growth analysis is rarely a clean or simple task.
How to avoid fantasy valuations in cannabis
Visions dance in the heads of key players of entire aisles in grocery stores and pharmacies dominated by marijuana and hemp products. Behind that, of course, there are visions of dynastic wealth.
